R. Todd Frederick

Rifaximin Treatment in Hepatic Encephalopathy

Nathan M. Bass, Kevin D. Mullen, Arun J. Sanyal et al. · New England Journal of Medicine · 2010 · 1.3K citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

Florence Wong, S. Chris Pappas, Michael P. Curry et al. · New England Journal of Medicine · 2021 · 448 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +12

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

Thomas Boyer, Arun J. Sanyal, Florence Wong et al. · Gastroenterology · 2016 · 305 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy

Kevin D. Mullen, Arun J. Sanyal, Nathan M. Bass et al. · Clinical Gastroenterology and Hepatology · 2013 · 203 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo

Catherine Frenette, Giuseppe Morelli, Mitchell L. Shiffman et al. · Clinical Gastroenterology and Hepatology · 2018 · 101 citations

Medicine, Pharmacology, Pharmacotherapy +17